Vedana Therapeutics Launches with USD 46 Million Series A Financing for Migraine Therapies
Vedana Therapeutics has launched with USD 46 million in Series A financing to advance next-generation migraine therapies. Backed by migraine experts and investors, the company is developing innovative treatments targeting clinically validated pathways to help patients achieve lasting freedom from migraine.
Series A Financing | 17/06/2026 | By News Bureau
AltrixBio Raises USD 5 Million Series A Financing and Appoints David Pass as CEO
Dr David Pass, a veteran of the pharma, biotech, and medical device sectors with a track record of scaling programs to over USD 1 billion in sales, succeeds AltrixBio Co-Founder and CEO Nancy Briefs, who led the company from inception and will now serve as Executive Chair.
Series A Financing | 18/09/2025 | By Dineshwori | 383
Abselion Secures EUR 6.6 Million in Series A Financing
Abselion will use the funds to drive the commercialisation and expand the capabilities of its Amperia system.
Series A Financing | 12/12/2024 | By Aishwarya | 251
Allink Biotherapeutics Secures USD 42 Million Series A Financing Round
The financing round was led by Lanchi Ventures, a preeminent global early-stage technology investor known for backing breakthrough innovations, with participation from an elite syndicate of new investors.
Series A Financing | 02/12/2024 | By Aishwarya | 220
Myricx Bio Secures EUR 90 Million in Series A Financing
Myricx Bio has raised EUR 90 Million (USD 114 Million) in the latest Series A financing round.
Series A Financing | 08/07/2024 | By Aishwarya | 522
YGION Biomedical Secures EUR 15 Million in Series A Financing for YGNITE
The funds will be used to further develop YGION's innovative YGNITE™ technology platform and advance their lead program, YG-01, into preclinical and clinical stages.
Series A Financing | 21/05/2024 | By Abha | 687
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy